Abstract:Reactive Oxygen Species (ROS)‐regulating nanomedicines for disease treatments mainly include ROS‐upregulating nanomedicines and ROS‐downregulating nanomedicines. Here, ROS‐upregulating nanomedicines can exert the toxic effect by employing nanoplatforms to enhance ROS generation in pathological sites for ROS‐induced toxic therapy, and ROS‐downregulating nanomedicines can scavenge excess ROS to maintain normal physiological process and avoid oxidative stress injuries for antioxidant therapy.Reactive oxygen species (ROS) play an essential role in physiological and pathological processes. Studies on the regulation of ROS for disease treatments have caused wide concern, mainly involving the topics in ROS‐regulating therapy such as antioxidant therapy triggered by ROS scavengers and ROS‐induced toxic therapy mediated by ROS‐elevation agents. Benefiting from the remarkable advances of nanotechnology, a large number of nanomaterials with the ROS‐regulating ability are developed to seek new and effective ROS‐related nanotherapeutic modalities or nanomedicines. Although considerable achievements have been made in ROS‐based nanomedicines for disease treatments, some fundamental but key questions such as the rational design principle for ROS‐related nanomaterials are held in low regard. Here, the design principle can serve as the initial framework for scientists and technicians to design and optimize the ROS‐regulating nanomedicines, thereby minimizing the gap of nanomedicines for biomedical application during the design stage. Herein, an overview of the current progress of ROS‐associated nanomedicines in disease treatments is summarized. And then, by particularly addressing these known strategies in ROS‐associated therapy, several fundamental and key principles for the design of ROS‐associated nanomedicines are presented. Finally, future perspectives are also discussed in depth for the development of ROS‐associated nanomedicines.

Redox regulation and its emerging roles in cancer treatment

Nanomaterial-based regulation of redox metabolism for enhancing cancer therapy

Reactive Oxygen Species-Based Nanomaterials for Cancer Therapy

Modulating Intracellular Oxidative Stress Via Engineered Nanotherapeutics

The progress of research on the application of redox nanomaterials in disease therapy

Targeting the Redox Landscape in Cancer Therapy

Recent advances of redox-responsive nanoplatforms for tumor theranostics

Unraveling mitochondria‐targeting reactive oxygen species modulation and their implementations in cancer therapy by nanomaterials

Redox dyshomeostasis strategy for tumor therapy based on nanomaterials chemistry

Modulation of redox homeostasis: A strategy to overcome cancer drug resistance

Roles of Ion Fluxes, Metabolism, and Redox Balance in Cancer Therapy

Redox‐Responsive Self‐Assembled Nanoparticles for Cancer Therapy

The double-edged roles of ROS in cancer prevention and therapy

The Cancer Antioxidant Regulation System in Therapeutic Resistance

The Role of Redox Environment in Tumors

Reactive Oxygen Species‐Regulating Strategies Based on Nanomaterials for Disease Treatment

Dual Role of Reactive Oxygen Species and their Application in Cancer Therapy

Targeting Reactive Oxygen Species Capacity of Tumor Cells with Repurposed Drug as an Anticancer Therapy

Nanomaterials for Tumor Hypoxia Relief to Improve the Efficacy of ROS-Generated Cancer Therapy

Modulation of reactive oxygen species in cancers: recent advances

Teaching the basics of reactive oxygen species and their relevance to cancer biology: Mitochondrial reactive oxygen species detection, redox signaling, and targeted therapies